Johnson & Johnson (NYSE:JNJ)
| 88.09 Data as of May 17 | +0.64 / +0.73%Today’s Change | 61.71 Today|||52-Week Range 88.20 | +25.66% Year-to-Date |
JNJ Regular Dividend: JNJ will begin trading ex-dividend on 05/23/13 with a $0.66 dividend payable to shareholders of record as of 05/28/13.
Latest JNJ News | Press Releases
| ASCO '13 Preview: Gilead's Big Cancer Debut May 15 / TheStreet.com | Earnings Miss at SurModics - Analyst Blog May 08 / Zacks.com |
| 5 Stocks Boosting The Drugs Industry Higher May 15 / TheStreet.com | 361 Capital Weekly Research Briefing May 07 / StockTwits |
| Stryker's Stock Looks Pricey May 15 / TheStreet.com | Growth outside QE required to curb distortions in asset prices May 03 / FT.com |
| Stock Market News for May 14, 2013 - Market News May 14 / Zacks.com | US woes take gloss off Avon sales Apr 30 / FT.com |
| Stock Market News for May 13, 2013 - Market News May 13 / Zacks.com | How women get to (and stay at) the top Apr 29 / Fortune |
Today’s Trading
| Previous close | 87.45 |
| Today’s open | 87.47 |
| Day’s range | 87.41 - 88.20 |
| Volume | 11,439,498 |
| Average volume (3 months) | 9,723,208 |
| Market cap | $247.4B |
| Dividend yield | 3.00% |
Data as of 4:02pm ET, 05/17/2013
Growth & Valuation
| Earnings growth (last year) | +10.60% |
| Earnings growth (this year) | +6.11% |
| Earnings growth (next 5 years) | +6.40% |
| Revenue growth (last year) | +3.45% |
| P/E ratio | 24.0 |
| Price/Sales | 2.84 |
| Price/Book | 3.78 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| PFEPfizer Inc | -0.29 | -0.99% |
| NVSNovartis AG | -0.86 | -1.15% |
| SNYSanofi SA | +0.29 | +0.53% |
| MRKMerck & Co Inc | -0.38 | -0.82% |
Data as of 4:00pm ET, 05/17/2013
Financials
| Next reporting date | July 16, 2013 |
| EPS forecast (this quarter) | $1.39 |
| Annual revenue (last year) | $67.3B |
| Annual profit (last year) | $10.9B |
| Net profit margin | 16.13% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
Chairman & Chief Executive Officer Alex Gorsky, MBA |
Chief Financial Officer & Vice President Dominic J. Caruso |
Corporate headquarters New Brunswick, New Jersey |
Forecasts


